JP2008189659A5 - - Google Patents

Download PDF

Info

Publication number
JP2008189659A5
JP2008189659A5 JP2008002754A JP2008002754A JP2008189659A5 JP 2008189659 A5 JP2008189659 A5 JP 2008189659A5 JP 2008002754 A JP2008002754 A JP 2008002754A JP 2008002754 A JP2008002754 A JP 2008002754A JP 2008189659 A5 JP2008189659 A5 JP 2008189659A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
aromatic heterocyclic
hydrogen atom
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008002754A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008189659A (ja
JP4328820B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2008002754A priority Critical patent/JP4328820B2/ja
Priority claimed from JP2008002754A external-priority patent/JP4328820B2/ja
Publication of JP2008189659A publication Critical patent/JP2008189659A/ja
Publication of JP2008189659A5 publication Critical patent/JP2008189659A5/ja
Application granted granted Critical
Publication of JP4328820B2 publication Critical patent/JP4328820B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008002754A 2007-01-10 2008-01-10 医薬組成物 Expired - Fee Related JP4328820B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008002754A JP4328820B2 (ja) 2007-01-10 2008-01-10 医薬組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007002904 2007-01-10
JP2008002754A JP4328820B2 (ja) 2007-01-10 2008-01-10 医薬組成物

Publications (3)

Publication Number Publication Date
JP2008189659A JP2008189659A (ja) 2008-08-21
JP2008189659A5 true JP2008189659A5 (enExample) 2008-11-13
JP4328820B2 JP4328820B2 (ja) 2009-09-09

Family

ID=39750102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008002754A Expired - Fee Related JP4328820B2 (ja) 2007-01-10 2008-01-10 医薬組成物

Country Status (1)

Country Link
JP (1) JP4328820B2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2689514C (en) * 2007-06-05 2015-09-29 Takeda Pharmaceutical Company Limited Heterobicyclic compounds as kinase inhibitors
JP5270553B2 (ja) 2007-08-23 2013-08-21 武田薬品工業株式会社 複素環化合物およびその用途
US8193363B2 (en) 2008-08-29 2012-06-05 Astrazeneca Ab Compounds suitable as precursors to compounds that are useful for imaging amyloid deposits
JO3101B1 (ar) 2008-12-02 2017-09-20 Takeda Pharmaceuticals Co مشتقات بنزوثيازول كعوامل مضادة للسرطان
NZ596445A (en) * 2009-06-24 2013-04-26 Boehringer Ingelheim Int New compounds, pharmaceutical composition and methods relating thereto
JPWO2011093423A1 (ja) * 2010-01-29 2013-06-06 田辺三菱製薬株式会社 （ｅ）−ヒドロキシイミノフェニル酢酸誘導体の製法
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EA201590626A1 (ru) * 2012-09-26 2015-07-30 Кова Компани, Лтд. Новое фенилацетамидное соединение и содержащая его фармацевтическая композиция

Similar Documents

Publication Publication Date Title
JP2008189659A5 (enExample)
CA2613303A1 (en) An oxime derivative for use as a glucokinase activator
US9670193B2 (en) Trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
Huang et al. Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles
US20130224151A1 (en) Use of FAAH Inhibitors for Treating Abdominal, Visceral and Pelvic Pain
JP2009534386A5 (enExample)
JP2008007519A5 (enExample)
JP2010530431A5 (enExample)
RU2012129168A (ru) Производные оксазина
NZ623838A (en) Pharmaceutical compositions for the treatment of diabetes mellitus
JP2018509418A5 (enExample)
JP2018502101A5 (enExample)
US20240287098A1 (en) Compositions and methods for treating cancer
JP2014506582A5 (enExample)
JP2016534124A5 (enExample)
JP2014518853A5 (enExample)
JP2018513190A5 (enExample)
CN103102348B (zh) 噁二唑类化合物及其制备方法、药物组合物及其用途
MY181731A (en) Azole benzene derivative
JP2014533735A (ja) 外寄生生物を防除するためのアリール誘導体の使用
JP2018509474A (ja) インダン酢酸誘導体を用いる肝疾患の治療方法
US20170065608A1 (en) Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome
AU2006236812A1 (en) Combinations, methods and compositions for treating cancer
BR112016019161B1 (pt) Amidas antimitóticas, composições farmacêuticas que as compreendem e uso das mesmas
JP2008500378A5 (enExample)